Our News
Preeclampsia Foundation helps provide patient perspectives in large five-year randomized control study to help answer the question could 162mg of aspirin be more effective at preventing preeclampsia than 81mg?
For more on the Preeclampsia Foundation's work to amplify all research related to biomarkers for improved prediction and diagnostic tools, please visit https://preeclampsia.org/biomarkers. INDIANAPOLIS, Feb. 13, 2025 /PRNewswire/ -- Roche announced...
By Amanda Yang, MS Evidence-based healthcare comes from trustworthy research. Research is designed carefully, so that it can be repeated and tested by other scientists. Wrong information or bad data may waste clinical resources or even cause harm to...
By Sig-Linda Jacobsen, MD Neurological symptoms are not uncommon in those who have preeclampsia. The most common symptom is severe headache. Some patients may also experience eclampsia, or seizures during pregnancy and the postpartum period.&nb...
Summary by Jennifer Mitchell, MPH, PhD Preeclampsia is a serious condition that can happen during pregnancy and affects 2-8% of pregnancies around the world. It can cause health problems for both the mother and the baby. Some studies suggest that no...
By Julie Reynolds, MD and Laney Poye As the Foundation often shares, research shows that women with a history of preeclampsia are two to four times more likely to develop cardiovascular disease (CVD). Researchers and patients both ask, “but wh...
_(4)1737997628.png)
The Preeclampsia Foundation announced today the recipients of its 2025 Peter Joseph Pappas Research Grants. Based on the recommendations of its Scientific Advisory Council, the Preeclampsia Foundation awarded two grants totaling $99,997 USD each to D...
It’s with unimaginable gratitude that we recognize Dr. Tom Easterling, as he retires from his role as Director of the Preeclampsia Foundation Medical Advisory Board. To talk about Dr. Easterling’s legacy is to talk about the 25 years of t...
"GAP—SPIRIN" is an evidence-based education campaign, encouraging the use of low-dose aspirin to help prevent preeclampsia and close the maternal health equity gap.
1732072344.png)
Strategic Roadmap to Address High Rates of Hypertension-related Maternal Mortality and Morbidity in Black Women
Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal mortality and can put both mother and baby at risk for problems during pregnancy. Women who had HDPs have postpartum risks of chronic hypertension up to ten times those ob...
Although underlying causes of preeclampsia are not fully understood, there is evidence suggesting a strong genetic component. Genetic risk factors for blood pressure have been shown to contribute to the risk of preeclampsia.
Related Articles
It's time to pull out your spring floral dresses and CELEBRATE YOU! Join us at a "I Got You, Sis!" Advocacy in Bloom Party as we gather around the table to raise awareness, build connections, and emp...
1739984081.jpg)
It's time to get dressed in your purple and peach and CELEBRATE YOU! Join us at a "I Got You, Sis!" Purple Peach Party as we gather around the table to raise awareness, build connections, and empower...
_41721308753.jpg)
It's time to slip on your sundresses and CELEBRATE YOU! Join us at a Sunset Soiree as we gather around the table to raise awareness, build connections, and empower one another on our journey to Black...
Our advocacy objectives are centered on providing patient support and education, raising public awareness, increasing research investment, and improving healthcare practices and quality.
Want to impact how your state and our nation handles maternity care?